Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies - Lambertini, M; Ceppi, M; Poggio, F (Ann Oncol, 2015)
et al.